Описание
Cognitive decline trajectories over a 20-year follow-up period are compared between Ginkgo biloba extract (EGb761) users and non-users in a population-based cohort study. The longitudinal data suggest an association between EGb761 intake and slower cognitive decline in elderly adults.
Figure 1
ChartSource Paper
Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study.Cite This Figure
![Figure 1: Cognitive decline trajectories over a 20-year follow-up period are compared between Ginkgo biloba extract (EGb761) users and non-users in a population-based cohort study. The longitudinal data suggest an association between EGb761 intake and slower cognitive decline in elderly adults.]() > Source: Hélène Amieva et al. "Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up popul." *PloS one*, 2013. PMID: [23326356](https://pubmed.ncbi.nlm.nih.gov/23326356/)
<figure> <img src="" alt="Cognitive decline trajectories over a 20-year follow-up period are compared between Ginkgo biloba extract (EGb761) users and non-users in a population-based cohort study. The longitudinal data suggest an association between EGb761 intake and slower cognitive decline in elderly adults." /> <figcaption>Figure 1. Cognitive decline trajectories over a 20-year follow-up period are compared between Ginkgo biloba extract (EGb761) users and non-users in a population-based cohort study. The longitudinal data suggest an association between EGb761 intake and slower cognitive decline in elderly adults.<br> Source: Hélène Amieva et al. "Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up popul." <em>PloS one</em>, 2013. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/23326356/">23326356</a></figcaption> </figure>